Authors/Disclosures
|
Victoria Lawson, MD, FAAN
(Department of Neurology, Dartmouth-Hitchcock Medical Center)
|
Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. |
|
Phillip C. Mongiovi, MD
(U of Rochester, Dept of Neurology)
|
Dr. Mongiovi has nothing to disclose. |
|
William D. Arnold, MD
|
Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care. |
|
Christopher Wallick, PharmD
(Avanir)
|
Dr. Wallick has received personal compensation for serving as an employee of Genentech. Dr. Wallick has stock in Genentech. |